DonCorleone77
Posted - 2 weeks ago
$DNLI Denali Therapeutics sees Fy24 opex increase of 5%-10% year-over-year Denali is providing updated guidance on cash operating expenses for FY24 and now anticipates an increase of approximately 5%-10% compared to 2023, which is an increase from previous guidance of equal to or less than FY23 cash operating expenses. This updated guidance is associated with increased activities to support filing of a BLA in early 2025 and commercial readiness for tividenofusp alfa in MPS II, and to accelerate the development of additional therapeutic programs in Denali's TV platform portfolio.
DonCorleone77
Posted - 2 weeks ago
$DNLI Denali Therapeutics reports Q3 EPS (63c), consensus (61c) There was no collaboration revenue for Q3, compared to $1.3M for Q3 of 2023. The decrease in collaboration revenue was primarily due to activities under the Biogen Collaboration Agreement. Cash, cash equivalents, and marketable securities were approximately $1.28B as of September 30, 2024.
RallyRaider
Posted - 10/28/24
$DNLI nice chart play to 31$
Estimize
Posted - 10/28/24
Estimize revenue expectations are 100.00% lower than that of Wall Street for $DNLI Q3 [Reporting 10/31 BMO]
http://www.estimize.com/intro/d
insiderbuyingselling
Posted - 10/23/24
$DNLI new insider selling: 40000 shares. http://insiderbuyingselling.com/?t=DNLI
net0trader
Posted - 1 month ago
$DNLI good pullback and nice hold at that 26 level. Liking the price action here, giving a good risk reward entry here.
briefingcom
Posted - 1 month ago
$DNLI: Denali Therapeutics was informed by its strategic partner Sanofi (SNY) that the K2 Phase 2 study evaluating the safety and efficacy of oditrasertib (SAR443820/DNL788) on serum neurofilament light chain levels in participants with multiple sclerosis was discontinued based on not meeting the primary and key secondary endpoints
Shlobby
Posted - 1 month ago
$DNLI need an sos green candle here
vjtweet
Posted - 09/27/24
$DNLI bought some with tight stop.
BobBijawklah
Posted - 09/25/24
$IBRX Another possible clinical partnership should be looked into with $dnli utilizing their delivery system that is able to pass through the blood brain barrier. Maybe something in gioblastoma with one of our Hank vaccines or possibly anktiva.
vjtweet
Posted - 09/24/24
$DNLI I will wait for decent entry points around 28.
CrazyCoolMedallions
Posted - 2 months ago
$DNLI Does anyone know when Denali’s Phase II/III DNL343 Regimen G HEALEY ALS Platform Trial is slated to end? Is it December 2024?
Laynester
Posted - 2 months ago
$DNLI We were alerted to DNLI a few days ago...based on long term trends, glad we bought in this morning at $26.40 at that time (see the daily graph). Now it's $31.90 (up 16%). Truly luck based on hard researched long term trends lines. We have a 7% trlr stop set - will drop that to 3.5% when one of our leading l-t indicators shows weakness. DLNI investors knew this was a winner.
Shlobby
Posted - 2 months ago
Time to climb a big mtn in $DNLI
Tomppa
Posted - 2 months ago
$DNLI I lost my nerves with all these new highs and those scary news that owners has been selling, I have seen too many times what happens when owners sells to up trend, even if it should not mean anything 😅
Shlobby
Posted - 2 months ago
$DNLI entered few days ago looking promising
net0trader
Posted - 2 months ago
@MaverikIT @IsabellaDC $DNLI still going… and volume coming in. Looking good for a big move
Tomppa
Posted - 2 months ago
$DNLI here we are, 52w highs in a strange day, wish I would own a lot more of this 😃
net0trader
Posted - 2 months ago
@MaverikIT @IsabellaDC $DNLI holding strong. Nice base here. @RonIsWrong you in this one?
GakiYoui_Atsu
Posted - 2 months ago
WIMI Hologram Cloud( $WIMI) had its price objective from Evaluate Research, $5.00 Average Target Price from Evaluate Research Lattice Semiconductor Co. ($LSCC) Receives $65.17 Average Target Price from Brokerages Analysts Set Denali Therapeutics Inc. ($DNLI) Target Price at $38.33 Comstock Resources, Inc. ($CRK) Receives $9.75 Average Target Price from Brokerages Brokerages Set IDEAYA Biosciences, Inc. ($IDYA) Target Price at $55.70
MysticChartReaderIQ69
Posted - 2 months ago
$DNLI was hoping for a dip today to get my nibble on but nice resistance to the market
MaverikIT
Posted - 2 months ago
@net0trader @IsabellaDC $SEZL ing $SNCR - steady $DNLI
Stock_Titan
Posted - 2 months ago
$DNLI Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
https://www.stocktitan.net/news/DNLI/denali-therapeutics-announces-successful-meeting-with-the-fda-and-e1czb5fxcy8n.html
MaverikIT
Posted - 08/26/24
@IsabellaDC @net0trader $DNLI - new 52wk$ hi @rxptgh
MaverikIT
Posted - 08/26/24
@IsabellaDC @net0trader @RonIsWrong $GLPG - damn this once 200'$ $SWTX $KYMR $VKTX $DNLI ...
Tomppa
Posted - 08/26/24
$DNLI all time high, nice to see you
MaverikIT
Posted - 3 months ago
@rxptgh $DNLI - that segment (neurodegenerative diseases) been quietly marching on
MaverikIT
Posted - 3 months ago
$DNLI +1.35 - knocking on 52wk$ hi
MaverikIT
Posted - 3 months ago
@IsabellaDC @net0trader @DonCorleone77 @CycleTrade @RonIsWrong @Cash4freedom @Im_not_Mr_Lebowski $DNLI +1.19
